Literature DB >> 25700540

Prevalence and management of gastrointestinal manifestations in Silver-Russell syndrome.

Céline Marsaud1, Sylvie Rossignol2, Patrick Tounian3, Irène Netchine2, Béatrice Dubern3.   

Abstract

OBJECTIVES: Silver-Russell syndrome (SRS) is an imprinted disorder characterised by intrauterine growth retardation, relative macrocephaly, failure to thrive, typical facial phenotype and frequent body asymmetry. Feeding difficulties are frequently noted, but no study described evolution of gastrointestinal signs during infancy and their management in SRS. The aim of this study was to describe these abnormalities in a large cohort of children with SRS.
DESIGN: We included 75 patients (median age 24.3 months (5.1-135.2)) in the study. We retrospectively analysed nutritional status before growth hormone therapy, the frequency of gastrointestinal signs, such as gastroesophageal reflux (GER), vomiting, constipation and feeding difficulties, and nutritional management.
RESULTS: Maternal uniparental disomy for chromosome 7 was found in 10 patients and 11p15 hypomethylation in 65 patients. Malnutrition (defined as a weight/expected weight for height ratio <80%) was detected in 70% of the children. Gastrointestinal signs were found in 77%, including severe vomiting before the age of 1 year in 50% of cases, persistent vomiting from the age of 1 year in 29% of cases and constipation in 20% of cases. Severe GER was diagnosed in 55% of children by 24 h oesophageal pH-metry. Feeding difficulties were described in 65% of cases, with indications for dietary enrichment in 49%. Enteral nutrition by gastrostomy was indicated in 22% of cases.
CONCLUSIONS: Digestive signs (GER, constipation) and malnutrition are frequent in children with SRS. The systematic exploration and management of these signs are crucial to improve the nutritional status of these children before initiating growth hormone therapy. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Silver Russell syndrome; digestive manifestations; failure to thrive; gastroesophageal reflux; malnutrition

Mesh:

Year:  2014        PMID: 25700540     DOI: 10.1136/archdischild-2013-305864

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

Review 1.  New developments in Silver-Russell syndrome and implications for clinical practice.

Authors:  Miho Ishida
Journal:  Epigenomics       Date:  2016-04-12       Impact factor: 4.778

2.  Diagnosis and management of Silver-Russell syndrome: first international consensus statement.

Authors:  Emma L Wakeling; Frédéric Brioude; Oluwakemi Lokulo-Sodipe; Susan M O'Connell; Jennifer Salem; Jet Bliek; Ana P M Canton; Krystyna H Chrzanowska; Justin H Davies; Renuka P Dias; Béatrice Dubern; Miriam Elbracht; Eloise Giabicani; Adda Grimberg; Karen Grønskov; Anita C S Hokken-Koelega; Alexander A Jorge; Masayo Kagami; Agnes Linglart; Mohamad Maghnie; Klaus Mohnike; David Monk; Gudrun E Moore; Philip G Murray; Tsutomu Ogata; Isabelle Oliver Petit; Silvia Russo; Edith Said; Meropi Toumba; Zeynep Tümer; Gerhard Binder; Thomas Eggermann; Madeleine D Harbison; I Karen Temple; Deborah J G Mackay; Irène Netchine
Journal:  Nat Rev Endocrinol       Date:  2016-09-02       Impact factor: 43.330

3.  Chronic Hypercapnic Respiratory Failure in an Adult Patient with Silver-Russell Syndrome.

Authors:  Mariko Hakamata; Satoshi Hokari; Yasuyoshi Ohshima; Masayo Kagami; Sakae Saito; Ikuko N Motoike; Taiki Abe; Nobumasa Aoki; Masachika Hayashi; Satoshi Watanabe; Toshiyuki Koya; Toshiaki Kikuchi
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

4.  Behavioural abnormalities in a novel mouse model for Silver Russell Syndrome.

Authors:  Grainne Iseult McNamara; Brittany Ann Davis; Dominic Michael Dwyer; Rosalind M John; Anthony Roger Isles
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

5.  Height and body mass index in molecularly confirmed Silver-Russell syndrome and the long-term effects of growth hormone treatment.

Authors:  Oluwakemi Lokulo-Sodipe; Eloïse Giabicani; Ana P M Canton; Nawfel Ferrand; Jenny Child; Emma L Wakeling; Gerhard Binder; Irène Netchine; Deborah J G Mackay; Hazel M Inskip; Christopher D Byrne; I Karen Temple; Justin H Davies
Journal:  Clin Endocrinol (Oxf)       Date:  2022-03-21       Impact factor: 3.523

6.  Phenotype of genetically confirmed Silver-Russell syndrome beyond childhood.

Authors:  Oluwakemi Lokulo-Sodipe; Lisa Ballard; Jenny Child; Hazel M Inskip; Christopher D Byrne; Miho Ishida; Gudrun E Moore; Emma L Wakeling; Angela Fenwick; Deborah J G Mackay; Justin Huw Davies; I Karen Temple
Journal:  J Med Genet       Date:  2020-02-13       Impact factor: 6.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.